Transcription of Cellular Therapies – Program Chairs: Baculovirus ...
{{id}} {{{paragraph}}}
Example: air traffic controller
Cellular Therapies – Program Chairs: Baculovirus ...
Viral Vectors & Vaccines Program Chairs: Cellular Therapies Program Chairs: Baculovirus Expression Technology Program Chairs: Otto-Wilhelm Merten, PhD G n thon Martin A. Giedlin, PhD Novartis Pharmaceuticals Corporation Manuel Carrondo, PhD Instituto de Biologia Amine A. Kamen, PhD McGill University Gary K. Lee, PhD Sangamo BioSciences, Inc. Experimental e Tecnol gica (iBET). Clifton E. McPherson, PhD Protein Sciences Corporation, A Sanofi Company SUNDAY MARCH 4, 2018. 3:00 pm 7:00 pm Welcome Reception and Registration in the Granby Ballroom Foyer, Third Floor MONDAY MARCH 5, 2018. 7:00 am 8:00 am Registration and Breakfast in the Granby Ballroom Foyer, Third Floor 8:00 am 8:30 am Meeting Overview in Momentum, Third Floor Viral Vectors & Vaccines Cellular Therapies Baculovirus Expression Technology Momentum, Third Floor Fusion, Third Floor Energy, Third Floor View Speaker Abstracts & Bios View Speaker Abstracts & Bios View Speaker Abstracts & Bios 8:30 am 9:15 am OneBac rAAV Scale-Up Production Platform with Serotype-Specific Successful Manufacturing of T-Cell Therapies : Challenges and The Complete Genome Sequence of a Trichoplusia ni Cell Line, Modulation of AAV Capsid Protein Stoichiometry Opportunities Tni-FNL.
2 ISBioTech 8th Spring Meeting (continued): TUESDAY MARCH 6, 2018• Viral Vectors & Vaccines Momentum, Third Floor Cellular Therapies Fusion, Third Floor
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: